ation, 1986-88; 1988-91 (Jury Comprehension--w/Greene-Goodman) Fund for Research on Dispute Resolution, 1989-91 (Predictions of Success--w/Goodman) National Institute of Health, 1991-95 (Cognition & Health--w/Croyle) National Institute of Health, 1993-94 (Health/sex memory: subcontract from UCSF/Catania) Leverhulme Trust,

ally, less than 400 can be treated therapeutically. This year the European Commission gave 144 million euros to develop 200 new therapies and the National Institute of Health allocated $3.5 billion to research orphan diseases. Yet some diseases are so rare that they remain stepchildren even among orphans. As a result, t